BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (1994) 67, 591-595
© 1994 British Institute of Radiology
doi: 10.1259/0007-1285-67-798-591

This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Pechoux, C
Right arrow Articles by Hasegawa, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Pechoux, C
Right arrow Articles by Hasegawa, H

Hepatocellular carcinoma diagnosed radiologically, treated by transcatheter arterial embolization and limited-field radiotherapy

C Le Pechoux 1,5,* Y Akine 2 N Tokita 2,* M Sumi 1 H Churei 1 K Takayasu 3 Y Muramatsu 3 F Wakao 3 and H Hasegawa 4

1 Department of Radiation Therapy, National Cancer Center Hospital, Tokyo, Japan 2 Department of Outpatient Clinic, National Cancer Center Hospital, Tokyo, Japan 3 Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan 4 Department of Ibaraki Prefectural Central Hospital, Tomobe, Ibaraki, Japan 5 Department of Centre Hospitalo-Universitaire H Mondor, Creteil, France

Even though the resection rate for hepatocellular carcinoma (HCC) has risen recently, many patients cannot be treated surgically because of the advanced stage of the tumour and/or coexisting cirrhosis. An alternative therapeutic approach for some of these patients is transcatheter arterial embolization (TAE) which has become very common in Japan. However, it is not a curative measure, and an additional therapy is required to eradicate the residual disease. In this communication, we report a case in which a patient with HCC has been successfully treated by TAE followed by limited-field radiotherapy. The results suggest that this is a very promising therapeutic approach for HCC and that the potential of limited-field radiotherapy for HCC with or without TAE also needs to be explored.

* Visiting researcher.

Received for publication August 25, 1993. Revision received November 8, 1993. Accepted for publication November 23, 1993.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 1994 by the British Institute of Radiology.